ABOG Oral Boards Obstetrics Practice Test

Maternal causes of oligohydramnios can be linked to various factors, and one significant cause includes the use of certain medications that may affect amniotic fluid production or lead to fluid depletion. For example, medications such as angiotensin-converting enzyme (ACE) inhibitors, certain antibiotics, and nonsteroidal anti-inflammatory drugs (NSAIDs) have been associated with reduced amniotic fluid levels through various mechanisms, including increased placental resistance or direct effects on renal function.

Understanding how medications influence amniotic fluid dynamics is important for the management of pregnancies affected by oligohydramnios. This knowledge allows for better assessment and monitoring of fetal well-being and the development of appropriate management strategies.

In contrast, conditions such as neural tube defects can lead to oligohydramnios due to renal anomalies but are not classified as direct maternal causes. Polyhydramnios, on the other hand, represents excessive amniotic fluid and is not related to oligohydramnios. Uteroplacental insufficiency is also a notable cause of oligohydramnios, but it relates more to fetal factors than maternal causes. Therefore, the influence of medications stands out as a clear maternal-related cause for oligohydramnios.